SPOTLIGHT: Allergan wins FDA OK for new therapy

The FDA has approved a new glaucoma treatment developed by Allergan. Combigan will be released by the end of the year, combining brimonidine and timolol in an eye droplet. Release

Suggested Articles

Inovio CEO J. Joseph Kim is undeterred by short sellers and other detractors who doubt his company can shuttle a COVID-19 DNA vaccine to market.

Adding entinostat to hormone therapy did not help patients with HR-positive, HER2-negative breast cancer live longer.

The data add to the evidence in support of the IL-6 drug ahead of a FDA decision to approve it in a rare disease served by Alexion’s Soliris.